期刊文献+

卡维地洛对心衰患者QT离散度的影响 被引量:1

The effect of carvedilol on chronic heart faiure pataent's QT dispersion
下载PDF
导出
摘要 目的 探索卡维地洛对心衰患者QT离散度的影响。方法 通过 47例卡维地洛治疗的心衰患者治疗前后心电图QTd分析 ,与 38例常规疗法的对照组患者比较有无统计学差异。结果 常规疗法患者QTd无明显变化 ,卡维地洛组治疗后QTd与治疗前比较 ,以及与对照组比较均显著缩小 ,P <0 .0 1。结论 卡维地洛使心衰患者QT离散度缩小 ,为其能有效干预CHF病理进程提供了心电学依据。 Objective:To study the effect of carvedilol on chronic heart faiure pataent's QT dispersion.Methods:Analyze 47 cases patient's cardiograph wich were treated with carvedilol,contrast to another group wich were treated without carvedilol.Results:If we didnot apply carvedilol to the patients ,their QT d have no notable variety. On the other hand,if the patients were treated with carvedilol,their QTd were reduced evidently.Conclusion:Carvedilol can reduce the patient's QTd.Basing on the cardiograph evidence,carvedilol can intervene in the pathological CHF effectively.
出处 《海南医学》 CAS 2003年第6期21-22,共2页 Hainan Medical Journal
关键词 卡维地洛 心力衰竭 QT离散度 心电图 保护作用 肾上腺素β受体阻滞剂 Carvedilol Chronic heart failure QT dispersion
  • 相关文献

参考文献7

  • 1惠波,王秉臣,郝玉明,刘凡,崔炜,杨新毅,刘兰燕,王建华,魏玲格,李拥军,齐华阁.卡维地洛对充血性心力衰竭患者心功能的影响[J].中华心血管病杂志,2001,29(7):430-430. 被引量:12
  • 2曾玉杰,冯义柏,于世龙,黄战军,杨海玉,苗立夫.卡维地洛对心脏缺血再灌注心律失常发生率的影响[J].临床心血管病杂志,2001,17(11):520-523. 被引量:2
  • 3惠波,郝玉明,刘凡,王秉臣.卡维地洛的分子心血管保护作用[J].中国新药杂志,2000,9(4):229-231. 被引量:12
  • 4Bristow MR.Gilbert EM,Abraham WT,et al.Carvedilol produces do se-related improvements in left ventricular function and survival in subjects with chronic heart failure.Circulation,1996,94:2807-16.
  • 5Ruffolo RR,Gellai M,Hieble JP,Willette RN,Nichols AJ.The pharmacology of carvedilol.Eur J Clin Pharmecol.1990,38(2 Suppl):82S-88S.
  • 6Goldsmith RL,Bigger JT,Bloomfield DM,et al.Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failure,AMJ Cardiol,1997,80(8):1101.
  • 7Barr CS,Naas A.Freman M,et al.QT dispersion and sudden unexpected death in chronic heart failure.Lancat,1994,343:327.

二级参考文献16

  • 1周斌,魏尔清.β受体阻滞药卡维地洛[J].中国新药杂志,1996,5(1):23-26. 被引量:10
  • 2李乐,金正均.卡维地洛的药理作用及临床应用近况[J].中国药学杂志,1996,31(9):515-517. 被引量:9
  • 35,White CM. Catecholamines and their blockade in congestive heart failu re. Am J Health Syst Pharm,1998,55(7)∶676
  • 49,oldsmith RL,Bigger JT,Bloomfield DM,et al. Long-term carv edilol therap y increases parasympathetic nervous system activty in chronic congestive heart f ailure. Am J Cardiol,1997,80(8)∶1101
  • 510,Das Gupta P,Broodhurst P,Paeymans Y,et al. Value of carvedilol in conges tive heart failure secondary to coronary artery diease. Am J Cardiol,1990,66 (15)∶1118
  • 611,Fuerstein GZ,Ruffolo RR.Carvedilol,a novel vasodilating betablocker with the potential for cadiovasculor organ protection. Eur Heart J,1996,17(Suppl B) ∶S24
  • 712,Yue TL,Liu T,Fuerstein G.Carvedilol,a new vasodilator and beta-adrenocepto r antagonist,inhibits oxygen radical mediated peroxidation. in swine ventricula r menbranes. Pharmacol Comm, 1992,(1)∶27
  • 813,Yue TL,Ma XL,Gu JL. Carvedilol inhibits activation of stress-activated prot ein kinase and reduces reperfusion injury in perfused rabbet heart. Eur J Phar macol,1998,345(1)∶61
  • 914,Ohlstein EH,Arleth AJ,Storer B.Carvedilol inhibits endothelin-1 biosynthesi s in cultured human coronary artery endothelial cells. J Mol Cell Cardiol,19 98,30(1)∶167
  • 1015,Yue TL,Ma XL,Wang X,et al. Possible involvement of stress-activated pro tein kinase signaling pathway and Fas receptor expression in prevention of ische mia/reperfusion induced cardiomyocyte apoptosis by cardedilol. Circ Res,1998 ,82(12)∶166

共引文献23

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部